[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-345494-105":59,"doc-detail-345494-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","genomic-analysis-of-t-cell-receptors-reveals-lynch-syndrome-specific-immune-signatures-received-30-january-2025","Genomic analysis ofT Cell receptors reveals lynch syndrome specific immune signatures - Received 30 January 2025","","The study investigates how DNA mismatch repair deficiency in Lynch syndrome shapes T cell receptor (TCR) repertoires and whether blood carries recognizable, syndrome-specific immune signatures. TCR sequencing was performed on 277 blood samples from Lynch syndrome cancer survivors, previvors, and controls, with matched colorectal cancers and pre-cancers. Up to 41% of the most expanded colorectal tumor TCRβs were detectable in Lynch syndrome blood with minimal expansion in controls. A validated classification model distinguished Lynch syndrome carriers using circulating TCRβ signatures independent of cancer history.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/genomic-analysis-of-t-cell-receptors-reveals-lynch-syndrome-specific-immune-signatures-received-30-january-2025/345494/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/genomic-analysis-of-t-cell-receptors-reveals-lynch-syndrome-specific-immune-signatures-received-30-january-2025/345494.png","ImageObject",300,407,{"name":92,"@type":93},"Theodore","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-07","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",13,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What does the study aim to determine about Lynch syndrome and T cells?","Question",{"text":113,"@type":114},"It examines whether Lynch syndrome produces TCR repertoires with detectable, syndrome-specific immune signatures in blood, and whether these signatures can be used to distinguish carriers from controls.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How was the TCR repertoire measured in the study?",{"text":118,"@type":114},"The work used TCR sequencing of 277 blood samples from Lynch syndrome cancer survivors, previvors, and controls, including matched colorectal cancers and pre-cancers.",{"name":120,"@type":111,"acceptedAnswer":121},"What key finding links colorectal tumors to circulating TCRs in Lynch syndrome carriers?",{"text":122,"@type":114},"Up to 41% of the most expanded colorectal tumor TCRβs were detectable in the blood of Lynch syndrome carriers, while expansion was minimal in controls.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},345494,1790820466,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},7971461740886,"https://ap-avatar.wpscdn.com/davatar_3d24733baf745e90a7e4bdd5f77d97b2","Article [https://doi.org/10.1038/s41467-026-71243-z](https://doi.org/10.1038/s41467-026-71243-z)  \nGenomic analysis ofT Cell receptors reveals lynch syndrome speciﬁc immune signatures  \nReceived: 30 January 2025  \n\n| Accepted: 17 March 2026 |\n| --- |\n| |\n| Check for updates |\n\nNan Deng1,13, Fahriye Duzagac 1,13, Ana M. Bolivar1,13, Laura Reyes-Uribe1, Melissa W. Taggart2, Selvi Thirumurthi3, Luigi Ricciardiello3, Patrick M. Lynch3, Y. Nancy You 4, Scott Kopetz 5, Paul Scheet 6, Gregory A. Lizee 7,8, Alexandre Reuben 9, Fatima Marin10, Marta Pineda 10, Krishna M. Sinha1, Ajay Bansal11,12, Gabriel Capella10 & Eduardo Vilar 1,5   \nLynch Syndrome (LS) provides the perfect context to understand DNA mismatch repair deﬁcient carcinogenesis, which is characterized by neoplastic lesions with high rates of shared neoantigens eliciting adaptive immunity through T cell receptor (TCR) recognition. However, the TCR landscape in LS carriers remains unexplored. Here, we perform TCR sequencing of 277 blood samples from LS cancer survivors, previvors, and controls, as well as matching colorectal cancers and pre-cancers. We show that up to 41% of the most expanded TCRβs from colorectal neoplasms are detectable in the blood of LS carriers, while showing minimal expansion in controls. In addition, we develop and validate a classiﬁcation model that distinguishes LS carriers from controls using circulating TCRβs signatures associated with LS independent of thecancer history and with cancer-free LS previvors. Together, our ﬁndings characterize circulating and tissue TCRβs associated with LS, thus representing a step toward identifying blood-based TCR biomarkers for immune surveillance.  \nLynch Syndrome (LS) is a genetic condition estimated to affect more than one million individuals in the United States1,2. LS carriers inherit a heterozygous germline pathogenic variant in one of four DNA mismatch repair (MMR) genes (MLH1, MSH2, MSH6, and PMS2), which predisposes them to develop different types of cancers, starting at a young age3. LS is the primary cause of hereditary colorectal cancer (CRC), conferring a 50-80% lifetime risk as well as a 40–60% for endometrial cancer (EC), and enhances the risk to develop multiple  \nother tumor types4. MMR deﬁciency occurs when cells acquire a second somatic hit in the alternate allele of the gene that harbors the germline pathogenic alteration. This event leads to the accumulation of hundreds of somatic mutations, primarily insertion-deletions (indels) in microsatellite (MS) loci5.  \nTherefore, malignant MMR-deﬁcient (MMRd) cells produce high levels of tumor-speciﬁc neoantigens (neoAgs), derived primarily from the MS indels, which trigger an anti-cancer immune response via the  \n1Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. 2Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. 3Department of Gastroenterology, Hepatology and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. 4Department of Colorectal Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. 5Department of GI Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. 6Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. 7Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. 8Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. 9Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. 10Department of Hereditary Cancer Program, Catalan Institute of Oncology- ICO, Hereditary Cancer Group, ONCOBELL Program, Institut d’Investigació Biomèdica de Bellvitge- IDIBELL, Ciber Oncología (CIBERONC) - Instituto de Salud Carlos III, L’Hospitalet de Llobregat, Barcelona, Spain. 11","cbCaiqTdiOnqNajf","https://ap.wps.com/l/cbCaiqTdiOnqNajf","pdf",3443068,18,"English","# Background\n## Lynch syndrome and DNA mismatch repair deficiency\n## Neoantigens and TCR recognition\n# Methods\n## TCR sequencing cohort\n## Analysis of blood and matched tissues\n# Results\n## Detectable tumor-expanded TCRβs in carriers\n## Classification model for carrier identification\n# Implications\n## Toward blood-based TCR biomarkers for immune surveillance","[{\"question\":\"What does the study aim to determine about Lynch syndrome and T cells?\",\"answer\":\"It examines whether Lynch syndrome produces TCR repertoires with detectable, syndrome-specific immune signatures in blood, and whether these signatures can be used to distinguish carriers from controls.\"},{\"question\":\"How was the TCR repertoire measured in the study?\",\"answer\":\"The work used TCR sequencing of 277 blood samples from Lynch syndrome cancer survivors, previvors, and controls, including matched colorectal cancers and pre-cancers.\"},{\"question\":\"What key finding links colorectal tumors to circulating TCRs in Lynch syndrome carriers?\",\"answer\":\"Up to 41% of the most expanded colorectal tumor TCRβs were detectable in the blood of Lynch syndrome carriers, while expansion was minimal in controls.\"}]","Genomic analysis ofT Cell receptors reveals lynch syndrome specific immune signatures - Received 30 January 2025 | PDF",1790057860,45,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4f50a7d30106776b57f57f135591decc.webp",983,1305,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6ce7cd6671a462a3ee628a21ab8f95a4.webp",982,1304,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b82ff9ba653fc6de12d29dd98e831e42.webp",981,1303,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ec47753bc6eca7e0ce4bf7b67428e417.webp",980,1301]